文献速递外周动脉疾病

冻存同种异体血管移植物在下肢血运重建中的系统评价与荟萃分析

Do Arterial Allografts Outperform Venous in Cryopreserved Bypass for Limb Salvage? A Systematic Review and Meta-Analysis of Infrainguinal Revascularization Outcomes.
PubMed 文献 · Ann Vasc Surg · 2026-03-27

该系统评价与荟萃分析纳入42项研究(2,237例患者,2,170条肢体),评估冻存动脉或静脉同种异体移植物用于腹股沟下血运重建的结局。汇总1年一期通畅率为51.1%,总生存率85.0%,累计大截肢率20.2%。动脉移植物通畅率(67.6%)高于静脉(39.6%),感染适应症通畅率(70.4%)优于非感染(44.2%),但证据确定性极低。

要点

  • 冻存同种异体移植物1年一期通畅率约51%,大截肢率约20%。
  • 动脉移植物1年通畅率高于静脉移植物(67.6% vs 39.6%)。
  • 感染适应症重建的通畅率优于非感染适应症(70.4% vs 44.2%)。

核心结论

  • 冻存同种异体移植物可用于复杂慢性肢体威胁性缺血的血运重建,但1年通畅率中等且异质性大。
  • 动脉移植物及感染适应症与更优的早期通畅率相关,需高质量对比研究优化移植物选择。

研究设计与样本

  • 系统评价与荟萃分析,检索报告冻存动脉或静脉同种异体移植物腹股沟下重建的研究,遵循PRISMA,注册号CRD42024579097。
  • 纳入42项研究,共2,237例患者、2,170条肢体;25项研究存在严重偏倚风险,17项为中等风险。
  • 采用随机效应单臂荟萃分析,按移植物类型和感染状态进行亚组分析;使用ROBINS-I评估偏倚风险,GRADE评估证据确定性。

主要发现

  • 汇总1年一期通畅率为51.1%(95%CI 40.9-61.4%)。
  • 汇总总生存率为85.0%(95%CI 81.1-88.9%)。
  • 累计大截肢率为20.2%(95%CI 15.7-24.7%)。
  • 动脉移植物1年一期通畅率为67.6%(95%CI 54.3-80.9%),静脉移植物为39.6%(95%CI 30.2-49.0%)。
  • 感染适应症重建的1年一期通畅率为70.4%(95%CI 55.2-85.6%),非感染适应症为44.2%(95%CI 32.8-55.5%)。

关键数值与推荐

  • GRADE证据确定性为极低。
  • 次要结局(再干预和移植物相关并发症)采用叙述性总结。

临床怎么用

  • 在自体静脉不可用或人工材料不适用时,冻存同种异体移植物可作为保肢血运重建的选择。
  • 动脉移植物或感染适应症可能获得更优的早期通畅率,但需结合患者具体情况个体化决策。

局限性

  • 纳入研究多为非随机设计,25项存在严重偏倚风险,证据确定性极低。
  • 研究间异质性显著,缺乏稳健的对比研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cryopreserved allografts remain a viable option for infrainguinal revascularization in limb salvage when autologous veins are unavailable or prosthetic material is undesirable. Uncertainty persists regarding comparative outcomes by allograft type (arterial vs venous) and clinical indication (infectious vs noninfectious settings). This systematic review and meta-analysis summarizes outcomes and key evidence gaps. METHODS: A systematic search of studies reporting infrainguinal reconstructions with cryopreserved arterial or venous allografts was conducted according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (International Prospective Register of Systematic Reviews: CRD42024579097). Primary outcomes were 1-year primary patency, overall survival, and cumulative major amputation. Random-effects single-arm meta-analyses were performed with subgroup analyses by graft type and infection status. Risk of bias was assessed using Risk Of Bias In Nonrandomized Studies - of Interventions and certainty of evidence using Grading of Recommendation Assessment, Development, and Evaluation (GRADE). Secondary outcomes, including reintervention and graft-related complications, were narratively summarized. RESULTS: Forty-two studies (2,237 patients; 2,170 limbs) were included: 25 were at serious risk of bias and 17 at moderate. Pooled 1-year primary patency was 51.1% (95% confidence interval [CI] 40.9-61.4%), overall survival 85.0% (95% CI 81.1-88.9%), and cumulative major amputation 20.2% (95% CI 15.7-24.7%). Arterial grafts had higher patency (67.6%; 95% CI 54.3-80.9%) than venous (39.6%; 95% CI 30.2-49.0%). Reconstructions for infection had superior patency (70.4%; 95% CI 55.2-85.6%) compared with noninfectious indications (44.2%; 95% CI 32.8-55.5%). GRADE certainty was very low. CONCLUSION: Cryopreserved allografts enable limb salvage in complex chronic limb-threatening ischemia but show modest 1-year patency and substantial heterogeneity. Arterial conduit and use in infection were associated with superior early patency; robust comparative studies are required to optimize graft selection.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Buongiovanni G, Murigu A, Wong KHF, et al. Do Arterial Allografts Outperform Venous in Cryopreserved Bypass for Limb Salvage? A Systematic Review and Meta-Analysis of Infrainguinal Revascularization Outcomes. Ann Vasc Surg. 2026. PMID: 41903844. doi:10.1016/j.avsg.2026.03.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。